"use strict";(self.webpackChunkmain=self.webpackChunkmain||[]).push([[1877],{8041:(M,O,e)=>{e.d(O,{z:()=>d});var t=e(5e3),m=e(8481),c=e(5017),C=e(4110);let d=(()=>{class _{constructor(){this.cvcShowLabel=!0,this.cvcShowTooltip=!0,this.showIcon=!0}}return _.\u0275fac=function(n){return new(n||_)},_.\u0275cmp=t.Xpm({type:_,selectors:[["cvc-attribute-tag"]],inputs:{cvcAttrValue:"cvcAttrValue",iconPropertyType:"iconPropertyType",cvcShowLabel:"cvcShowLabel",cvcShowTooltip:"cvcShowTooltip",showIcon:"showIcon"},decls:5,vars:8,consts:[["nz-icon","",3,"nzType"]],template:function(n,s){1&n&&(t.TgZ(0,"nz-tag"),t._UZ(1,"i",0),t.ALo(2,"evidenceEnumDisplay"),t._uU(3),t.ALo(4,"evidenceEnumDisplay"),t.qZA()),2&n&&(t.xp6(1),t.Q6J("nzType",t.Dn7(2,2,s.cvcAttrValue,"icon-name",s.iconPropertyType)),t.xp6(2),t.hij(" ",t.lcZ(4,6,s.cvcAttrValue),"\n"))},directives:[m.j,c.Ls],pipes:[C.D],styles:["[_nghost-%COMP%]{display:inline-block}"],changeDetection:0}),_})()},4226:(M,O,e)=>{e.d(O,{_:()=>o});var t=e(9808),m=e(8481),c=e(6905),C=e(5017),d=e(404),_=e(5e3);let o=(()=>{class n{}return n.\u0275fac=function(p){return new(p||n)},n.\u0275mod=_.oAB({type:n}),n.\u0275inj=_.cJS({imports:[[t.ez,m.X,C.PV,d.cg,c.s]]}),n})()},8766:(M,O,e)=>{e.d(O,{P:()=>E});var t=e(9808),m=e(6042),c=e(6949),C=e(404),d=e(7525),_=e(1825),o=e(3075),n=e(1894),s=e(8144),p=e(5e3);let E=(()=>{class g{}return g.\u0275fac=function(I){return new(I||g)},g.\u0275mod=p.oAB({type:g}),g.\u0275inj=p.cJS({imports:[[t.ez,o.u5,o.UX,m.sL,C.cg,d.j,s.zf,n.Jb,c.WG,_.A]]}),g})()},3997:(M,O,e)=>{e.d(O,{m:()=>D});var t=e(5e3),m=e(6123),c=e(7630),C=e(8929),d=e(7625),_=e(9169),o=e(7525),n=e(9808),s=e(8227),p=e(6612),E=e(6042),g=e(2643),T=e(2683);function I(y,R){if(1&y){const l=t.EpF();t.TgZ(0,"cvc-org-selector-btn-group",5),t.NdJ("selectedOrgChange",function(u){return t.CHM(l),t.oxw().mostRecentOrg=u}),t.TgZ(1,"button",6),t.NdJ("click",function(){t.CHM(l);const u=t.oxw();return u.moderate(u.evidenceStatuses.Accepted)}),t._uU(2),t.qZA()()}if(2&y){const l=t.oxw();t.Q6J("selectedOrg",l.mostRecentOrg),t.xp6(2),t.hij(" Accept ",l.entityType," ")}}let D=(()=>{class y{constructor(l,v,u){this.revertEvidenceGQL=l,this.revertAssertionGQL=v,this.networkErrorService=u,this.rejectOnly=!1,this.onModerated=new t.vpe,this.evidenceStatuses=c.RTy,this.isSubmitting=!1,this.showConfirm=!1,this.destroy$=new C.xQ,this.moderateAssertionMutator=new m.U(u),this.moderateEvidenceMutator=new m.U(u)}moderate(l){var v,u;let f;this.isSubmitting=!0,f="EvidenceItem"===this.entityType?this.moderateEvidenceMutator.mutate(this.revertEvidenceGQL,{input:{evidenceItemId:this.entityId,organizationId:null===(v=this.mostRecentOrg)||void 0===v?void 0:v.id,newStatus:l}}):this.moderateAssertionMutator.mutate(this.revertAssertionGQL,{input:{assertionId:this.entityId,organizationId:null===(u=this.mostRecentOrg)||void 0===u?void 0:u.id,newStatus:l}}),f.submitSuccess$.pipe((0,d.R)(this.destroy$)).subscribe(i=>{i&&(this.isSubmitting=!1,this.showConfirm=!1,this.onModerated.emit(l))}),f.submitError$.pipe((0,d.R)(this.destroy$)).subscribe(i=>{i&&(this.isSubmitting=!1,this.showConfirm=!1,this.onModerated.emit(i))}),f.isSubmitting$.pipe((0,d.R)(this.destroy$)).subscribe(i=>{this.isSubmitting=i})}ngOnInit(){if(void 0===this.viewer)throw new Error("Must pass in a viewer to the CvcEntitySubscriptionButtonComponent");if(void 0===this.entityId)throw new Error("Must pass in an id to the CvcEntitySubscriptionButtonComponent");if(void 0===this.entityType)throw new Error("Must pass in an entityType to the CvcEntitySubscriptionButtonComponent");this.mostRecentOrg=this.viewer.mostRecentOrg}ngOnDestroy(){this.destroy$.next(),this.destroy$.complete()}}return y.\u0275fac=function(l){return new(l||y)(t.Y36(c.MYm),t.Y36(c._jb),t.Y36(_.Y))},y.\u0275cmp=t.Xpm({type:y,selectors:[["cvc-moderate-entity-buttons"]],inputs:{viewer:"viewer",entityType:"entityType",entityId:"entityId",rejectOnly:"rejectOnly"},outputs:{onModerated:"onModerated"},decls:7,vars:4,consts:[[1,"center"],[3,"nzSpinning"],[3,"selectedOrg","selectedOrgChange",4,"ngIf"],["nzDanger","","nzType","primary",3,"selectedOrg","selectedOrgChange"],["cvcOrgSelectorBtn","","nzDanger","","nzType","primary","nzSize","large","nz-button","",3,"click"],[3,"selectedOrg","selectedOrgChange"],["cvcOrgSelectorBtn","","nzType","primary","nzSize","large","nz-button","",3,"click"]],template:function(l,v){1&l&&(t.TgZ(0,"div",0)(1,"nz-spin",1),t.YNc(2,I,3,2,"cvc-org-selector-btn-group",2),t._uU(3," \xa0 "),t.TgZ(4,"cvc-org-selector-btn-group",3),t.NdJ("selectedOrgChange",function(f){return v.mostRecentOrg=f}),t.TgZ(5,"button",4),t.NdJ("click",function(){return v.moderate(v.evidenceStatuses.Rejected)}),t._uU(6),t.qZA()()()()),2&l&&(t.xp6(1),t.Q6J("nzSpinning",v.isSubmitting),t.xp6(1),t.Q6J("ngIf",!v.rejectOnly),t.xp6(2),t.Q6J("selectedOrg",v.mostRecentOrg),t.xp6(2),t.hij(" Reject ",v.entityType," "))},directives:[o.W,n.O5,s.q,p.m,E.ix,g.dQ,T.w],styles:["[_nghost-%COMP%]{display:block}.center[_ngcontent-%COMP%]{display:flex;justify-content:center}"]}),y})()},3217:(M,O,e)=>{e.d(O,{e:()=>f});var t=e(5e3),m=e(6123),c=e(7630),C=e(8929),d=e(7625),_=e(9169),o=e(6042),n=e(2643),s=e(2683),p=e(404),E=e(5017),g=e(3640),T=e(7525),I=e(8144),D=e(8227),y=e(6612);function R(i,A){if(1&i&&(t.TgZ(0,"span"),t._uU(1),t.qZA()),2&i){const r=t.oxw();t.xp6(1),t.hij("Revert this ",r.entityType," to Submitted?")}}function l(i,A){if(1&i){const r=t.EpF();t.TgZ(0,"span")(1,"cvc-org-selector-btn-group",8),t.NdJ("selectedOrgChange",function(a){return t.CHM(r),t.oxw(2).mostRecentOrg=a}),t.TgZ(2,"button",9),t.NdJ("click",function(){return t.CHM(r),t.oxw(2).revert()}),t._uU(3,"Revert"),t.qZA()()()}if(2&i){const r=t.oxw(2);t.xp6(1),t.Q6J("selectedOrg",r.mostRecentOrg)}}function v(i,A){if(1&i){const r=t.EpF();t.TgZ(0,"span")(1,"button",10),t.NdJ("click",function(){return t.CHM(r),t.oxw(2).showConfirm=!1}),t._uU(2,"Cancel"),t.qZA()()}}function u(i,A){if(1&i&&(t.TgZ(0,"nz-spin",5)(1,"nz-space",6),t.YNc(2,l,4,1,"span",7),t.YNc(3,v,3,0,"span",7),t.qZA()()),2&i){const r=t.oxw();t.Q6J("nzSpinning",r.isSubmitting)}}let f=(()=>{class i{constructor(r,h,a){this.revertEvidenceGQL=r,this.revertAssertionGQL=h,this.networkErrorService=a,this.onReverted=new t.vpe,this.isSubmitting=!1,this.showConfirm=!1,this.destroy$=new C.xQ,this.revertAssertionMutator=new m.U(a),this.revertEvidenceMutator=new m.U(a)}revert(){var r,h;let a;this.isSubmitting=!0,a="EvidenceItem"===this.entityType?this.revertEvidenceMutator.mutate(this.revertEvidenceGQL,{input:{evidenceItemId:this.entityId,organizationId:null===(r=this.mostRecentOrg)||void 0===r?void 0:r.id,newStatus:c.RTy.Submitted}}):this.revertAssertionMutator.mutate(this.revertAssertionGQL,{input:{assertionId:this.entityId,organizationId:null===(h=this.mostRecentOrg)||void 0===h?void 0:h.id,newStatus:c.RTy.Submitted}}),a.submitSuccess$.pipe((0,d.R)(this.destroy$)).subscribe(P=>{P&&(this.isSubmitting=!1,this.showConfirm=!1,this.onReverted.emit(!0))}),a.submitError$.pipe((0,d.R)(this.destroy$)).subscribe(P=>{P&&(this.isSubmitting=!1,this.showConfirm=!1,this.onReverted.emit(P))}),a.isSubmitting$.pipe((0,d.R)(this.destroy$)).subscribe(P=>{this.isSubmitting=P})}handleConfirmModalCancel(){this.showConfirm=!1}ngOnInit(){if(void 0===this.viewer)throw new Error("Must pass in a viewer to the CvcEntitySubscriptionButtonComponent");if(void 0===this.entityId)throw new Error("Must pass in an id to the CvcEntitySubscriptionButtonComponent");if(void 0===this.entityType)throw new Error("Must pass in an entityType to the CvcEntitySubscriptionButtonComponent");this.mostRecentOrg=this.viewer.mostRecentOrg}ngOnDestroy(){this.destroy$.next(),this.destroy$.complete()}}return i.\u0275fac=function(r){return new(r||i)(t.Y36(c.MYm),t.Y36(c._jb),t.Y36(_.Y))},i.\u0275cmp=t.Xpm({type:i,selectors:[["cvc-revert-entity-button"]],inputs:{viewer:"viewer",entityType:"entityType",entityId:"entityId"},outputs:{onReverted:"onReverted"},decls:7,vars:5,consts:[["nz-button","","nz-tooltip","Revert to Submitted","nzSize","small",3,"nzLoading","click"],["nz-icon","","nzType","undo"],[3,"nzVisible","nzContent","nzTitle","nzFooter","nzVisibleChange","nzOnCancel"],["confirmModalTitle",""],["confirmModalContent",""],[3,"nzSpinning"],["nzDirection","horizontal"],[4,"nzSpaceItem"],[3,"selectedOrg","selectedOrgChange"],["cvcOrgSelectorBtn","","nzType","primary","nzSize","small","nz-button","",3,"click"],["nz-button","","nzSize","small",3,"click"]],template:function(r,h){if(1&r&&(t.TgZ(0,"button",0),t.NdJ("click",function(){return h.showConfirm=!0}),t._UZ(1,"i",1),t.qZA(),t.TgZ(2,"nz-modal",2),t.NdJ("nzVisibleChange",function(P){return h.showConfirm=P})("nzOnCancel",function(){return h.handleConfirmModalCancel()}),t.YNc(3,R,2,1,"ng-template",null,3,t.W1O),t.YNc(5,u,4,1,"ng-template",null,4,t.W1O),t.qZA()),2&r){const a=t.MAs(4),P=t.MAs(6);t.Q6J("nzLoading",h.isSubmitting),t.xp6(2),t.Q6J("nzVisible",h.showConfirm)("nzContent",P)("nzTitle",a)("nzFooter",null)}},directives:[o.ix,n.dQ,s.w,p.SY,E.Ls,g.du,T.W,I.NU,I.$1,D.q,y.m],styles:["[_nghost-%COMP%]{display:block}"]}),i})()},694:(M,O,e)=>{e.d(O,{G:()=>g});var t=e(9808),m=e(6042),c=e(6949),C=e(5017),d=e(404),_=e(3640),o=e(7525),n=e(8144),s=e(1825),p=e(3075),E=e(5e3);let g=(()=>{class T{}return T.\u0275fac=function(D){return new(D||T)},T.\u0275mod=E.oAB({type:T}),T.\u0275inj=E.cJS({imports:[[t.ez,p.u5,p.UX,m.sL,C.PV,d.cg,_.Qp,o.j,n.zf,c.WG,s.A]]}),T})()},6204:(M,O,e)=>{e.d(O,{v:()=>_});var t=e(7630);const m={evidenceType:{[t.kqt.Diagnostic]:"Evidence pertains to a variant's impact on patient diagnosis (cancer subtype)",[t.kqt.Functional]:"Evidence pertains to a variant that alters biological function from the reference state",[t.kqt.Oncogenic]:"Evidence pertains to a somatic variant's involvement in tumor pathogenesis as described by the Hallmarks of Cancer",[t.kqt.Predictive]:"Evidence pertains to a variant's effect on therapeutic response",[t.kqt.Predisposing]:"Evidence pertains to a germline variant's role in conferring susceptibility to disease (including pathogenicity evaluations)",[t.kqt.Prognostic]:"Evidence pertains to a variant's impact on disease progression, severity, or patient survival"},assertionType:{[t.uBv.Diagnostic]:"Assertion pertains to a variant's impact on patient diagnosis (cancer subtype)",[t.uBv.Predictive]:"Assertion pertains to a variant's effect on therapeutic response",[t.uBv.Predisposing]:"Assertion pertains to a germline variant's role in conferring susceptibility to disease (including pathogenicity evaluations)",[t.uBv.Prognostic]:"Assertion pertains to a variant's impact on disease progression, severity, or patient survival",[t.uBv.Oncogenic]:"Assertion pertains to a somatic variant's role in driving tumor formation, growth, and other processes related to the Hallmarks of Cancer"},variantOrigin:{[t.huM.Somatic]:"Variant is a mutation, found only in tumor cells, having arisen in a specific tissue (non-germ cell), and is not expected to be inherited or passed to offspring",[t.huM.RareGermline]:"Variant is found in every cell (not restricted to tumor/diseased cells) and is thought to exist in less than 1% of the population relevant to this evidence item",[t.huM.CommonGermline]:"Variant is found in every cell (not restricted to tumor/diseased cells) and is thought to exist in at least 1% of the population relevant to this evidence item",[t.huM.Unknown]:"The variant origin is uncertain based on the available evidence",[t.huM.Na]:"The variant type (e.g., expression) is not compatible (or easily classified) with the CIViC concept of variant origin",[t.huM.Mixed]:"Variants in the Molecular Profile span multiple Origin types."},evidenceLevel:{[t.Sx0.A]:"Proven/consensus association in human medicine",[t.Sx0.B]:"Clinical trial or other primary patient data supports association",[t.Sx0.C]:"Individual case reports from clinical journals",[t.Sx0.D]:"In vivo or in vitro models support association",[t.Sx0.E]:"Indirect evidence"},evidenceLevelBrief:{[t.Sx0.A]:"Validated association",[t.Sx0.B]:"Clinical evidence",[t.Sx0.C]:"Case Study",[t.Sx0.D]:"Preclinical evidence",[t.Sx0.E]:"Inferential association"},therapyInteractionType:{[t.wkr.Combination]:"The therapies listed were used as part of a combination therapy approach",[t.wkr.Sequential]:"The therapies listed were used at separate timepoints in the same treatment plan",[t.wkr.Substitutes]:"The therapies listed are often considered to be of the same family, or behave similarly in a treatment setting"},evidenceRating:{1:"Poor - Claim is not supported well by experimental evidence. Results are not reproducible, or have very small sample size. No follow-up is done to validate novel claims",2:"Adequate - Evidence is not well supported by experimental data, and little follow-up data is available. Experiments may lack proper controls, have small sample size, or are not statistically convincing",3:"Average - Evidence is convincing, but not supported by a breadth of experiments. May be smaller scale projects, or novel results without many follow-up experiments. Discrepancies from expected results are explained and not concerning",4:"Strong - Well supported evidence. Experiments are well controlled, and results are convincing. Any discrepancies from expected results are well-explained and not concerning",5:"Excellent - Solid, well supported evidence from a lab or journal with respected academic standing. Experiments are well controlled, and results are clean and reproducible across multiple replicates. Evidence confirmed using separate methods"}},c={significance:{PREDICTIVE:{ADVERSE_RESPONSE:{EvidenceItem:"Associated with an adverse response to theraputic treatment",Assertion:"Associated with an adverse response to theraputic treatment"},REDUCED_SENSITIVITY:{EvidenceItem:"Response to treatment is lower than seen in other treatment contexts",Assertion:"Response to treatment is lower than seen in other treatment contexts"},RESISTANCE:{EvidenceItem:"Associated with clinical or preclinical resistance to treatment",Assertion:"Associated with clinical or preclinical resistance to treatment"},SENSITIVITYRESPONSE:{EvidenceItem:"Associated with clinical or preclinical response to treatment",Assertion:"Associated with a clinical or preclinical response to treatment"},NA:{EvidenceItem:"Clinical Significance is not applicable",Assertion:"Clinical Significance is not applicable"}},DIAGNOSTIC:{POSITIVE:{EvidenceItem:"Associated with diagnosis of disease or subtype",Assertion:"Associated with diagnosis of disease or subtype"},NEGATIVE:{EvidenceItem:"Associated with lack of disease or subtype",Assertion:"Associated with lack of disease or subtype"}},PROGNOSTIC:{BETTER_OUTCOME:{EvidenceItem:"Demonstrates better than expected clinical outcome",Assertion:"Demonstrates better than expected clinical outcome"},POOR_OUTCOME:{EvidenceItem:"Demonstrates worse than expected clinical outcome",Assertion:"Demonstrates worse than expected clinical outcome"},Na:{EvidenceItem:"Clinical Significance is not applicable",Assertion:"Clinical Significance is not applicable"}},PREDISPOSING:{PATHOGENIC:{Assertion:"Very strong evidence the variant is pathogenic"},LIKELY_PATHOGENIC:{Assertion:"Strong evidence (>90% certainty) the variant is pathogenic"},BENIGN:{Assertion:"Very strong evidence the variant is benign"},LIKELY_BENIGN:{Assertion:"Not expected to have a major effect on disease"},UNCERTAIN_SIGNIFICANCE:{Assertion:"Does not meet the ACMG/AMP criteria for pathogenic/benign, or the evidence is conflicting"},Na:{EvidenceItem:"Clinical Significance is not applicable"},PREDISPOSITION:{EvidenceItem:"Germline variant has predisposing potential for cancer, and may meet ACMG/AMP criteria supporting pathogenic or benign classification."},PROTECTIVENESS:{EvidenceItem:"Germline variant has properties that protect individuals from acquiring cancer."}},ONCOGENIC:{ONCOGENICITY:{EvidenceItem:"Somatic variant has oncogenic potential for driving cancer, and may meet ClinGen/CGC/VICC criteria supporting pathogenic or benign classification."},PROTECTIVENESS:{EvidenceItem:"Somatic variant has a protective role and minimizes co-occuring driver variants, tumor malignancy, or other oncogenic tumor properties."},ONCOGENIC:{Assertion:"Very strong evidence the variant is oncogenic."},LIKELY_ONCOGENIC:{Assertion:"Strong evidence the variant is oncogenic."},BENIGN:{Assertion:"Very strong evidence the variant does not have oncogenic properties."},LIKELY_BENIGN:{Assertion:"Strong evidence the variant does not have oncogenic properties."},UNCERTAIN_SIGNIFICANCE:{Assertion:"Does not meet guideline criteria for oncogenic/benign, or the evidence is conflicting."}}},evidenceDirection:{PREDICTIVE:{SUPPORTS:{EvidenceItem:"The experiment or study supports this variant's response to a therapy"},DOES_NOT_SUPPORT:{EvidenceItem:"The experiment or study does not support, or was inconclusive of an interaction between this variant and a therapy"}},DIAGNOSTIC:{SUPPORTS:{EvidenceItem:"The experiment or study supports this variant's impact on the diagnosis of disease or subtype"},DOES_NOT_SUPPORT:{EvidenceItem:"The experiment or study does not support this variant's impact on diagnosis of disease or subtype"}},PROGNOSTIC:{SUPPORTS:{EvidenceItem:"The experiment or study supports this variant's impact on prognostic outcome"},DOES_NOT_SUPPORT:{EvidenceItem:"The experiment or study does not support a prognostic association between variant and outcome"}},PREDISPOSING:{Na:{EvidenceItem:"Evidence Direction is not applicable"},SUPPORTS:{EvidenceItem:"The evidence supports a pathogenic or a protective role for a germline variant in cancer."},DOES_NOT_SUPPORT:{EvidenceItem:"The evidence supports a benign (if Clinical Significance is Predisposition) or lack or protective (if Clinical Significance is Protectiveness) role for a germline variant in cancer."}},FUNCTIONAL:{SUPPORTS:{EvidenceItem:"The experiment or study supports this variant causing alteration or non-alteration of the gene product function"},DOES_NOT_SUPPORT:{EvidenceItem:"The experiment or study does not support this variant causing alteration or non-alteration of the gene product function"}},ONCOGENIC:{NA:{EvidenceItem:"Evidence Direction is not applicable for Oncogenic Evidence Type"},SUPPORTS:{EvidenceItem:"The evidence supports an oncogenic or protective role for a somatic variant"},DOES_NOT_SUPPORT:{EvidenceItem:"The evidence does not support an oncogenic or protective role for a somatic variant"}}},assertionDirection:{PREDICTIVE:{SUPPORTS:{Assertion:"The Assertion and associated Evidence Items support this variant's response to a therapy"},DOES_NOT_SUPPORT:{Assertion:"The Assertion and associated evidence does not support, or was inconclusive of an interaction between this variant and a therapy"}},DIAGNOSTIC:{SUPPORTS:{Assertion:"The Assertion and associated Evidence Items support this variant's impact on the diagnosis of disease or subtype"},DOES_NOT_SUPPORT:{Assertion:"The Assertion and associated evidence does not support this variant's impact on diagnosis of disease or subtype"}},PROGNOSTIC:{SUPPORTS:{Assertion:"The Assertion and associated Evidence Items support this variant's impact on prognostic outcome"},DOES_NOT_SUPPORT:{Assertion:"The Assertion and associated evidence does not support a prognostic association between variant and outcome"}},PREDISPOSING:{SUPPORTS:{Assertion:"The Assertion and associated Evidence Items support a variant's impact on predisposing outcome"}},FUNCTIONAL:{SUPPORTS:{Assertion:"The Assertion and associated Evidence Items support this variant causing alteration or non-alteration of the gene product function"},DOES_NOT_SUPPORT:{Assertion:"The Assertion and associated evidence does not support this variant causing alteration or non-alteration of the gene product function"}},ONCOGENIC:{SUPPORTS:{Assertion:"The Assertion and associated Evidence Items support a variant's oncogenic, benign, or uncertain significance"}}}};var d=e(5e3);let _=(()=>{class o{transform(s,p,E,g){return p&&s?function C(o,n,s,p){let E;return E=s&&p?c[o][s][n][p]:m[o][n],E||""}(p,s,E,g):""}}return o.\u0275fac=function(s){return new(s||o)},o.\u0275pipe=d.Yjl({name:"enumTooltip",type:o,pure:!0}),o})()}}]);